Safety of Cholinesterase Inhibitors and NMDA Receptors Antagonists for the Treatment of Patients with Dementia

Safety of Cholinesterase Inhibitors and NMDA Receptors Antagonists for the Treatment of Patients with Dementia

For the treatment of dementia and Alzheimer’s disease, acetylcholinesterase inhibitors (donepezil, rivastigmine, galantamine) and/or the non-competitive inhibitor of N-methyl-D-aspartate receptors (NMDA receptors) memantine are currently used. The administration of these drugs can help temporarily i...

Full description

Bibliographic Details
Main Authors: A. P. Pereverzev, O. D. Ostroumova, O. N. Tkacheva, Y. V. Kotovskaya
Format: Article
Language:Russian
Published: Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation  2019-12-01
Series:Безопасность и риск фармакотерапии
Subjects:
dementia
drug safety
adverse drug reactions
donepezil
rivastigmine
galantamine
memantine
Online Access:https://www.risksafety.ru/jour/article/view/154

Internet

https://www.risksafety.ru/jour/article/view/154

Similar Items